🟢 GeneDx is trading 10.02% up today as biotech and diagnostics strength may support shares

GeneDx is trading at $71.17, up 10.02%, despite broad U.S. indexes trading lower; biotech and diagnostics strength may be supporting the move.

• The supplied alert context noted the XBI was up 1.2% early in the session.
• No fresh company-specific announcement was identified for October 29. The next scheduled earnings report is November 9.
• Trading volume information was not available in the provided price context.